Pfizer Asks FDA for Emergency Approval of Its COVID Antiviral Pill

pfizer asks fda for emergency approval of its covid antiviral pill

Sumary of Pfizer Asks FDA for Emergency Approval of Its COVID Antiviral Pill:

  • The overwhelming efficacy achieved in our recent clinical study of Paxlovid, and its potential to help save lives and keep people out of the hospital if authorized, underscores the critical role that oral antiviral therapies could play in the battle against COVID-19,” Pfizer chairman and CEO Albert Bourla, said in a company statement.
  • Paxlovid is a combination of a new molecule developed specifically to disable SARS-CoV-2 and ritonavir, an HIV medication that helps slow the breakdown of the coronavirus-specific molecule.

Want to know more click here go to source.

From -

Close

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close